35Pharma

Respira

This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

ShouTi

This biopharmaceutical company develops oral small molecule therapeutics for patients with chronic metabolic, cardiovascular and pulmonary diseases.

BioFactor Therapeutics AB

This pharmaceutical developer creates recombinant protein therapies for patients with metabolic and endocrine disorders.

Corteria

This biopharmaceutical company develops therapeutic drugs for patients with obesity and heart failure subpopulations.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

BYOMass

This company develops biologic and small molecule drugs targeting the TGF-beta superfamily to treat metabolic, fibrotic and age-related diseases for patients with unmet needs.